drugset / Trial / NCT02059460

Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney

NCT02059460

RandomizedSingle-groupOpen-labelPrevention

Summary

To study the impact of intra and post-operative Terlipressin infusion on the occurrence of acute kidney injury after LDLT To investigate perioperative Neutrophil Gelatinase Associated Lipocalin (NGAL) changes and study the effect of Terlipressin on NGAL blood levels

Timeline

Start
2013-05
Primary completion
2016-12
Completion
2016-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 1 ug/kg Other
Subject Terlipressin Peptide 4 ug/kg Other

Indications